ChengDa Pharmaceuticals Co. Ltd. (301201) — Cash Flow-to-Debt Ratio
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow-to-Debt Ratio of 0.10x as of December 2024, meaning its operating cash flow of CN¥28.65 Million could theoretically repay 0% of its total liabilities (CN¥290.77 Million) in one year. See ChengDa Pharmaceuticals Co. Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ChengDa Pharmaceuticals Co. Ltd. Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for ChengDa Pharmaceuticals Co. Ltd. across 6 annual periods. Also explore ChengDa Pharmaceuticals Co. Ltd. net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year debt coverage analysis for ChengDa Pharmaceuticals Co. Ltd.. For market capitalisation and broader financial context, see market cap of ChengDa Pharmaceuticals Co. Ltd..
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥28.65 Million | CN¥290.77 Million | ▼ -91.0% |
| 2023 | 1.09x | CN¥192.07 Million | CN¥176.40 Million | ▲ +141.7% |
| 2022 | 0.45x | CN¥47.67 Million | CN¥105.81 Million | ▼ -16.9% |
| 2021 | 0.54x | CN¥83.14 Million | CN¥153.30 Million | ▼ -68.3% |
| 2020 | 1.71x | CN¥128.97 Million | CN¥75.30 Million | ▲ +379.9% |
| 2019 | 0.36x | CN¥67.52 Million | CN¥189.21 Million | — |